Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

被引:37
|
作者
Wu, Qimei [1 ]
Yang, Xiaoyu [1 ]
Zhang, Yu [1 ]
Zhang, Lei [1 ]
Feng, Linyin [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, 555 Chong Zhi Rd, Shanghai 201203, Peoples R China
关键词
Chronic mild stress; Parkinson's disease; alpha-synuclein; Dopamine; Microglia; INDUCED NEUROTOXICITY; DOPAMINERGIC-NEURONS; CORTISOL RELEASE; SEX-DIFFERENCES; MOUSE MODEL; BRAIN; ONSET; NEURODEGENERATION; ACTIVATION; MICROGLIA;
D O I
10.1016/j.expneurol.2016.09.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Daily stress is associated with increased risk for various diseases, and numerous studies have provided evidence that environmental stress leads to deleterious effects on the central nervous system. However, it remains unclear whether chronic stress exacerbates the progression of Parkinson's disease (PD). To investigate this hypothesis, we determined the effect of chronic mild stress (CMS) on the pathogenesis of PD in a transgenic mice line that overexpresses the human A53T mutant alpha-synuclein (A53T Tg mice). We show that when exposed to CMS, male, but not female, A53TTg mice developed profound motor disabilities and exhibited olfactory sensitivity deficits. Pathological analysis also identified robust dopaminergic neuron degeneration and strong reduction of dopamine levels in A53T Tg male mice who underwent CMS treatment. Systematic examination of the abnormal aggregation of a-synuclein revealed a profound increase of inclusion in A53TTg male mice subject to CMS resembling key pathological changes of PD. An insight into the mechanism underlying stress leading to the acceleration of neurodegeneration in those with generic susceptibility, was revealed by evidence of microglia activation and elevated pro-inflammatory factor levels in A53T Tg male mice following CMS. Notably, these effects of CMS on the pathogenesis of PD showed a remarkable sexual dimorphism: only male A53T Tg mice exhibited exacerbation of the progression of PD. However, the molecular and cellular bases for this difference remains to be elucidated. Our results indicate a causative role for chronic mild stress using a PD animal model. Based on these findings, we propose that CMS acts as an environmental risk factor that leads to neuroinflammation and progressive neurodegeneration on a background of PD susceptibility. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 71
页数:11
相关论文
共 50 条
  • [21] Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T alpha-synuclein mutation
    Huang, Yue
    Chegini, Fariba
    Chua, Germaine
    Murphy, Karen
    Gai, Weiping
    Halliday, Glenda M.
    TRANSLATIONAL NEURODEGENERATION, 2012, 1
  • [22] Glutathione S-transferase polymorphisms and onset age in α-synuclein A53T mutant Parkinson's disease
    Golbe, Lawrence I.
    Di Iorio, Giuseppe
    Markopoulou, Katerina
    Athanassiadou, Aglaia
    Papapetropoulos, Spiridon
    Watts, Ray L.
    Vance, Jeffery M.
    Bonifati, Vincenzo
    Williams, Tanishia A.
    Spychala, John R.
    Stenroos, E. Scot
    Johnson, Williams G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2007, 144B (02) : 254 - 258
  • [23] Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients
    Longo, Gabriela S.
    Pinhel, Marcela A. S.
    Gregorio, Michele L.
    Oliveira, Bruno A. P.
    Quinhoneiro, Driele C. G.
    Tognola, Waldir A.
    Oliveira, Fabio N.
    Cezario, Sabrina M.
    Sado, Caroline L.
    Nakazone, Marcelo A.
    Calastri, Maria C. J.
    Souza, Doroteia R. S.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2015, 73 (06) : 506 - 509
  • [24] Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease
    Kumar, Sonu
    Sarkar, Anita
    Sundar, Durai
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (02) : 305 - 309
  • [25] Stabilization of α-synuclein protein with aging and familial Parkinson's disease-linked A53T mutation
    Li, WX
    Lesuisse, C
    Xu, YQ
    Troncoso, JC
    Price, DL
    Lee, MK
    JOURNAL OF NEUROSCIENCE, 2004, 24 (33): : 7400 - 7409
  • [26] Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
    Tayebi, Nahid
    Parisiadou, Loukia
    Berhe, Bahafta
    Gonzalez, Ashley N.
    Serra-Vinardell, Jenny
    Tamargo, Raphael J.
    Maniwang, Emerson
    Sorrentino, Zachary
    Fujiwara, Hideji
    Grey, Richard J.
    Hassan, Shahzeb
    Blech-Hermoni, Yotam N.
    Chen, Chuyu
    McGlinchey, Ryan
    Makariou-Pikis, Chrissy
    Brooks, Mieu
    Ginns, Edward I.
    Ory, Daniel S.
    Giasson, Benoit I.
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (04) : 198 - 208
  • [27] Distinct Region-Specific α-Synuclein Oligomers in A53T Transgenic Mice: Implications for Neurodegeneration
    Tsika, Elpida
    Moysidou, Maria
    Guo, Jing
    Cushman, Mimi
    Gannon, Patrick
    Sandaltzopoulos, Raphael
    Giasson, Benoit I.
    Krainc, Dimitri
    Ischiropoulos, Harry
    Mazzulli, Joseph R.
    JOURNAL OF NEUROSCIENCE, 2010, 30 (09): : 3409 - 3418
  • [28] DNA damage preceding dopamine neuron degeneration in A53T human α-synuclein transgenic mice
    Wang, Degui
    Yu, Tianyu
    Liu, Yongqiang
    Yan, Jun
    Guo, Yingli
    Jing, Yuhong
    Yang, Xuguang
    Song, Yanfeng
    Tian, Yingxia
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 481 (1-2) : 104 - 110
  • [29] MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian
    Mo, Mingshu
    Xiao, Yousheng
    Huang, Shuxuan
    Cen, Luan
    Chen, Xiang
    Zhang, Limin
    Luo, Qin
    Li, Shaomin
    Yang, Xinling
    Lin, Xian
    Xu, Pingyi
    ONCOTARGET, 2017, 8 (01) : 15 - 28
  • [30] The increase of α-synuclein and alterations of dynein in A53T transgenic and aging mouse
    Wang, Yiqing
    Sun, Zhenjie
    Du, Shouyun
    Wei, Hongyu
    Li, Xiuming
    Li, Xiaojing
    Shen, Jiahui
    Chen, Xinya
    Cai, Zenglin
    JOURNAL OF CLINICAL NEUROSCIENCE, 2022, 96 : 154 - 162